SAUSALITO, CA, January 12, 2011 (Press-News.org) Millions of Americans have likely been injured by Darvocet and Darvon over the past several decades. But who's ultimately responsible? It's a question that will soon be answered as more and more Darvon and Darvocet injury lawsuits are filed. If you've been injured, it's in your best interests to find out more.
What Did Eli Lilly & Xanodyne Pharma Know?
And more importantly - when did they know it? Darvon/Darvocet lawyers say that the answer to those questions will soon be answered. However, they say that if these manufacturers (Eli Lilly, Darvon; Xanodyne Pharmaceuticals, Darvocet) follow the lead of other big drug companies, then chances are that they simply covered their ears, closed their eyes and decided that not conducting their own studies were in their best interests - much to the horror of the thousands of patients potentially harmed by the drug.
Drug Companies Required To Provide Safe Products
Drug companies are required to test their drugs before marketing them to the American public and should take additional action whenever they find out new information. While Darvon and Darvocet were approved by the FDA years ago, chances are that they would not be approved today. Product liability lawyers say that, in effect, this was another case of the FDA - which has reported more than 3,000 cases of serious Darvon and Darvocet side effects such as suicide, addiction and overdose - sitting on its hands and not following up, forcing or even requesting drug companies to do the right studies.
Although many say that the FDA didn't act responsibly, it's clear that drug companies became aware of injuries and risks after these drugs were banned in England and Europe back in 2005. Yet, the companies never instituted their own studies. They simply let the drugs remain on the market - putting profits over patient safety. So, who really is ultimately responsible - the FDA or the drug companies?
Responsibility Ultimately Falls On Drug Companies
Product liability lawyers say that injured consumers or patients often don't understand that even though the FDA certainly should have acted sooner in this situation, that doesn't mean that there is no recourse. There is. While you can't sue the FDA for failing to act, you can seek redress from the drug companies who knew - or should have known - that these drugs were bad. Drug companies bear the ultimate burden of making sure their products are effective and safe. That is especially true in this case as patients could have received the same benefits from Tylenol without taking the same risks of suffering fatal heart arrhythmias, heart attacks, suicide and overdose.
Sending A Message That Patient Safety Comes First
Americans have seen drug company after drug company do more for their stockholders than for those who buy and use their products. Ironically, many believe that while some drugs are deemed unsafe to give to those living in other countries, they're generally safe for Americans until proven 100% unsafe - even though this country should theoretically be a leader in this area. It's the people who hold drug companies responsible for their actions that are sending an important message, which is that patient safety should - and must - come first.
If you've been injured by Darvon, Darvocet or another propoxyphene-based drug, contact an experienced attorney to discuss your situation and determine whether filing a lawsuit is in your best interests.
Online since 1999, www.FreeAdvice.com provides consumers and small businesses with balanced and comprehensive legal information covering over 125 legal topics. These useful and professionally prepared answers to thousands of legal questions are written, reviewed, and updated by lawyers from leading law firms across the country. For further information, please contact us at 240-462-5858
Darvocet & Darvon Injuries: Who Is Ultimately Responsible?
Millions of Americans have likely been injured by Darvocet and Darvon over the past several decades. But who's ultimately responsible? It's a question that will soon be answered as more and more Darvon and Darvocet injury lawsuits are filed.
2011-01-12
ELSE PRESS RELEASES FROM THIS DATE:
Sean Sherk Introduces High Elevation Training Mask for MMA Workouts
2011-01-12
Elevation Training Mask today announced the sales of its training equipment, which is specifically designed to improve cardiovascular stamina and simulate high stress situations. Former world champion and current top contender Sean Sherk helped create the mask for high altitude training in his personal MMA workouts and is now excited to offer the mask for order at trainingmask.com.
"I've been using masks for about 3 years now in my own training and had always kept it a secret, because I knew it was a huge advantage for me in the gym and in the cage. Being able to simulate ...
Upside Software Announces a Major Release: UpsideContract V7
2011-01-12
Upside Software Inc., the global leader in enterprise contract management software, is proud to announce the availability of UpsideContract Version 7, a major release for its award winning software suite.
"Today's buyers of enterprise contract management software expect applications to be quick, easy to use and flexible," said Debbie Wilson, Research Director, Procurement Strategies & Systems, Gartner, Inc.
"V7 delivers exceptional performance. Improved speed and seamless navigation between areas take contracting to the next level," said Ashif Mawji, President and ...
Luxury Mansion Available for Corporate Event Space, Offered by RDS Real Estate
2011-01-12
An affluent Colleyville homeowner is making his house available for rent to businesses as a conference facility. Ron Sturgeon, owner of the 14,000 square-foot executive home, had it custom built specifically for renting out to businesses and companies looking for a place to hold retreat-style events.
"This $3-million luxury mansion...makes the ideal corporate home rental for any corporate retreat. Business retreats allow you to focus on the real work: team building, strategic planning, envisioning, priority setting, role clarification and decision-making," says Sturgeon.
There ...
The Public Helped Name 50 New Businesses via NamingForce.com in 2010
2011-01-12
The product and business naming website NamingForce.com announces that in 2010 over 50 new businesses, products, and websites were named through its service. Naming Force uses crowdsourcing to help generate creative names for products, businesses, and websites.
Crowdsourcing is the practice of taking a traditionally private task and opening it up to the public. Normally, it would be too costly for most entrepreneurs and small businesses to hire professional branding services; now they turn to Naming Force for help.
In 2010, more than 50 successful names were generated ...
Stem Cell Therapy Cream Science Opens Door for Anti-Aging Creams and Anti-Wrinkle Creams
2011-01-12
While many scientists may state that stem cells are the key to longer and healthier lives, some are not waiting on the technology for that and are using it in the anti-aging industry to bring unmatched results in wrinkle removal. The ant-wrinkle and skin cream industry has been in a state of remission as far as advancements in the industry for decades.
While some skin care creams do show a marked reduction in wrinkles, it is a short term loss and not something that has a real and lasting effect. Most of the skin care creams on the market swell the skin to give the appearance ...
Qsan Launches F400Q FC & iSCSI Multiprotocol Storage Systems
2011-01-12
The F400Q multiprotocol systems are specially designed for high availability applications and featured with Fibre Channel and iSCSI ports in each RAID controller. The iSCSI ports can be activated for Qsan's system built-in remote replication function - QReplica or used for widely approved iSCSI functions. The unique multiprotocol feature allows users to integrate the applications and data from the FC and IP networks in the same F400Q storage system without extra infrastructure cost. The F400Q storage systems can provide users for dual active protection, high availability ...
Molecular medicine could avert predicted catastrophic vision loss in the aged
2011-01-11
Chennai, India (January 9, 2011) - While age-related vision loss of catastrophic proportions is predicted in coming decades, rising from 17 million patients today to 55 million by the year 2050, it's possible this catastrophe could be averted and lost vision even restored using molecular medicine.
These are the words of Stuart Richer, OD, PhD, speaking at the 10th annual meeting and International Conference on Recent Trends in Therapeutic Advancement of Free Radical Science, in Chennai, India today.
Dr. Richer says modern medicine is just beginning to evaluate ...
Wave power could contain fusion plasma
2011-01-11
Researchers at the University of Warwick's Centre for Fusion Space and Astrophysics and the UK Atomic Energy Authority's Culham Centre for Fusion Energy, may have found a way to channel the flux and fury of a nuclear fusion plasma into a means to help sustain the electric current needed to contain that very same fusion plasma.
The researchers used large scale computer simulations to confirm a longstanding prediction by US researchers that high energy alpha particles born in fusion reactions will be key to generating fusion power in the next planned generation of tokamaks. ...
Single cell studies identify coactivator role in fat cell maturation
2011-01-11
HOUSTON - (Jan. 10, 2011) – All fat cells are not the same – a fact that has implications in the understanding and treatment of type 2 diabetes and obesity, said researchers from Baylor College of Medicine (www.bcm.edu) in a report that appears in the current issue of the Journal of Cell Biology (http://www.jcb.rupress.org/).
The amount of fat in each cell and the central transcription factor, PPAR gamma (peroxisome proliferator activated receptor gamma), can vary widely, but the fat cells (adipocytes) can maintain stable levels of master switches known as steroid receptor ...
Study shows a serious risk of side effects when having latent tuberculosis therapy over age 65
2011-01-11
A new study found that there is a serious increased risk of side effects requiring hospitalization in people over the age of 65 who are going through latent tuberculosis infection therapy, according to a study published in CMAJ (Canadian Medical Association Journal) (pre-embargo link only) http://www.cmaj.ca/embargo/cmaj091824.pdf.
Latent tuberculosis therapy has been shown to reduce the development of active tuberculosis (TB) disease and is used as a way to control tuberculosis in Canada and the United States. Deciding to treat a person with latent tuberculosis therapy ...
LAST 30 PRESS RELEASES:
Lead-free alternative discovered for essential electronics component
BioCompNet: a deep learning workflow enabling automated body composition analysis toward precision management of cardiometabolic disorders
Skin cancer cluster found in 15 Pennsylvania counties with or near farmland
For platforms using gig workers, bonuses can be a double-edged sword
Chang'e-6 samples reveal first evidence of impact-formed hematite and maghemite on the Moon
New study reveals key role of inflammasome in male-biased periodontitis
MD Anderson publicly launches $2.5 billion philanthropic campaign, Only Possible Here, The Campaign to End Cancer
Donors enable record pool of TPDA Awards to Neuroscience 2025
Society for Neuroscience announces Gold Sponsors of Neuroscience 2025
The world’s oldest RNA extracted from woolly mammoth
Research alert: When life imitates art: Google searches for anxiety drug spike during run of The White Lotus TV show
Reading a quantum clock costs more energy than running it, study finds
Early MMR vaccine adoption during the 2025 Texas measles outbreak
Traces of bacteria inside brain tumors may affect tumor behavior
Hypertension affects the brain much earlier than expected
Nonlinear association between systemic immune-inflammation index and in-hospital mortality in critically ill patients with chronic obstructive pulmonary disease and atrial fibrillation: a cross-sectio
Drift logs destroying intertidal ecosystems
New test could speed detection of three serious regional fungal infections
New research on AI as a diagnostic tool to be featured at AMP 2025
New test could allow for more accurate Lyme disease diagnosis
New genetic tool reveals chromosome changes linked to pregnancy loss
New research in blood cancer diagnostics to be featured at AMP 2025
Analysis reveals that imaging is overused in diagnosing and managing the facial paralysis disorder Bell’s palsy
Research progress on leptin in metabolic dysfunction-associated fatty liver disease
Fondazione Telethon announces CHMP positive opinion for Waskyra™, a gene therapy for the treatment of Wiskott-Aldrich syndrome (WAS)
Vaccine Innovation Center, Korea University College of Medicine hosts an invited training program for Ethiopian Health Ministry officials
FAU study finds small group counseling helps children thrive at school
Research team uncovers overlooked layer of DNA that may shape disease risk
Study by Incheon National University could transform skin cancer detection with near-perfect accuracy
New study reveals how brain fluid flow predicts survival in glioblastoma
[Press-News.org] Darvocet & Darvon Injuries: Who Is Ultimately Responsible?Millions of Americans have likely been injured by Darvocet and Darvon over the past several decades. But who's ultimately responsible? It's a question that will soon be answered as more and more Darvon and Darvocet injury lawsuits are filed.


